Relay runs away with $400M series C on back of protein conformation platform

Protein motion company Relay Therapeutics Inc. (Cambridge, Mass.) raised $400 million on Dec. 20 in an untranched series C led by new investor SoftBank Vision Fund. Relay President and CEO Sanjiv Patel told BioCentury the round will provide multiple years of runway and allow Relay to move several of its lead

Read the full 518 word article

User Sign In